Results 141 to 150 of about 6,194,408 (253)
National Forum on COVID-19 Vaccine : practitioners
Practitioners have been and continue to be on the front lines in the fight against COVID-19. Now that COVID-19 vaccines are available, work must continue to deliver safe, effective, and equitable vaccination to people in communities across the country ...
core
Dual pKa Lipid Nanoparticles for Lung‐tropic mRNA Delivery and pH‐Programmed Endosomal Escape
Lipid nanoparticles’ bottleneck lies in low endosomal escape efficiency and liver‐dominant delivery after intravenous administration. To overcome these limitations, we present a stepwise pH‐programmed lipid nanoparticle system enabled by our newly synthesized ionizable lipid.
Seong Gi Lim +12 more
wiley +1 more source
COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID. [PDF]
Butzin-Dozier Z +15 more
europepmc +1 more source
COVID-19 science update ; 2021-03-19 (81)
From the Office of the Chief Medical Officer, CDC COVID-19 Response, and the CDC Library, Atlanta GA. Intended for use by public health professionals responding to the COVID-19 pandemic.Disclaimer: The purpose of the CDC COVID-19 Science Update is to ...
core
Tumor‐associated inflammation retains antibody‐targeted or non‐specific antibody conjugated nanoparticles within the tumor microenvironment. Magnetic Particle Imaging (MPI) enables non‐invasive detection and differentiation of tumors from other organs, owing to higher nanoparticle retention by inflammatory cells in the tumor periphery.
Preethi Korangath +9 more
wiley +1 more source
Younger Brazilians hit by COVID-19 – What are the implications?
Raphael Mendonça Guimarães, DSc PhD +4 more
doaj +1 more source
Cutaneous Squamous Cell Carcinoma Across the Pre-COVID-19, COVID-19 and Post-COVID-19 Eras: Epidemiology, Risk Stratification, Tumour Aggressiveness, and Clinical Outcomes. [PDF]
Manole M +11 more
europepmc +1 more source
COVID-19 science update ; Edition 2020-10-20
From the Office of the Chief Medical Officer, CDC COVID-19 Response, and the CDC Library, Atlanta GA. Intended for use by public health professionals responding to the COVID-19 pandemic.2020_10_20_Science-Update_Final-Public.pdfAntibody Responses to SARS-
core
COVID-19 Vaccine Safety Technical (VaST) Subgroup Technical Report : March 29, 2021 [PDF]
The Advisory Committee on Immunization Practices (ACIP) COVID-19 Vaccine Safety Technical (VaST) Subgroup has reviewed post-authorization Covid-19 vaccine safety data on a weekly basis since the start of the U.S. vaccination program.
core

